Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, September 27 2016 12:43pm ET - U.S. Markets close in 3 hours and 17 minutes.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Diagnostic Substances News
Latest News
Monday, Sep 26, 2016
·Meridian Expands Molecular Test Technology License with Eiken Chemical Co., Ltd.
GlobeNewswire - Mon 1:15 pm ET
·Chembio Awarded Grant from U.S. Department of Agriculture to Develop Point-of-Care Diagnostic Test for Bovine Tuberculosis
GlobeNewswire - Mon 8:50 am ET
Friday, Sep 23, 2016
·Palatin Technologies Receives Audit Opinion with Going Concern Explanation
PR Newswire - Fri Sep 23
·Chembio Expands Exclusive Distribution Agreements with Isla Lab to Include Puerto Rico and U.S. Virgin Islands
GlobeNewswire - Fri Sep 23
·Venaxis Reports Option Inducement Grants for New Employees Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire - Fri Sep 23
·Palatin Technologies Presents Bremelanotide Neurobiology and Treatment Efficacy Review at World Meeting on Sexual Medicine
PR Newswire - Fri Sep 23
Thursday, Sep 22, 2016
·Dr. Mark Schiller to present PEER at American College of Private Physicians
GlobeNewswire - Thu Sep 22
Wednesday, Sep 21, 2016
·MYnd Analytics Letter to Shareholders
GlobeNewswire - Wed Sep 21
·MYnd Analytics Announces Conversion of Outstanding Notes Following Closing on Last Tranche of $6.0 Million Financing and Recapitalization Including a Reverse Stock Split and Elimination of 99% of Outstanding Warrants
GlobeNewswire - Tue Sep 20
Tuesday, Sep 20, 2016
·Bioline Launches New SensiFAST(TM) Lyo-Ready No-ROX Mix
Thomson Reuters ONE - Tue Sep 20
·Bioline Launches New SensiFASTâ„¢ Lyo-Ready No-ROX Mix
GlobeNewswire - Tue Sep 20
·EXCLUSIVE: Cincinnati firm plays key role in battle against Zika virus
at - Tue Sep 20
·Venaxis Issues Shareholder Update
PR Newswire - Tue Sep 20
·Palatin Technologies, Inc. Reports Fourth Quarter And Fiscal Year 2016 Results
PR Newswire - Tue Sep 20
Monday, Sep 19, 2016
·Neogen's AccuPoint® Advanced receives AOAC approval
PR Newswire - Mon Sep 19
Wednesday, Sep 14, 2016
·Palatin Technologies, Inc. to Report Fourth Quarter Fiscal Year End 2016 Results; Teleconference and Webcast to be held on September 20, 2016
PR Newswire - Wed Sep 14
·Venaxis Announces Acquisition of BiOptix
PR Newswire - Tue Sep 13
Tuesday, Sep 13, 2016
·Atossa Genetics, Inc. Regains Compliance With NASDAQ Listing Requirement
Marketwire - Tue Sep 13
Monday, Sep 12, 2016
·Chembio to Present Today at the Rodman & Renshaw 18th Annual Global Investment Conference
GlobeNewswire - Mon Sep 12
·Atossa Genetics, Inc. to Present at Upcoming Investor Conferences in September 2016
Marketwire - Mon Sep 12
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Diagnostic Substances Headlines
More Finance RSS Feeds

Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?